Peer-reviewedCC BYThe Journal of clinical investigation
Modeling human neurodegeneration with iPSCs: opportunities, limitations, and the challenge of aging
- 1Center for Systems and Therapeutics, Gladstone Institutes, San Francisco, California, USA.
Related
- Pharmacological and non-pharmacological strategies targeting HIF signaling and hypoxia tolerance: opportunities and limitations for personalized interventions
- Data approaches for lifecourse research on early-life determinants of late-life health outcomes: opportunities, limitations, and tradeoffs
- Limitations in US Cancer Screening Rate Data and Opportunities to Improve Precision Prevention.
- Artificial Intelligence in Forensic Science: A Systematic Review and Meta-Analysis of Opportunities and Limitations
- Establishing a human co-infection challenge study of Streptococcus pneumoniae (Spn) and live attenuated influenza vaccine (LAIV) in older healthy adults: E xploring C o-infection with L ive Attenuated I nfluenza Vaccine and P neumococcu S in healthy old E r adults (ECLIPSE), a UK-based single-centre, single-blind randomised controlled trial
BibTeX
@article{wang2026modeling,
title = {{Modeling human neurodegeneration with iPSCs: opportunities, limitations, and the challenge of aging}},
author = {Shijie Wang and Lisa Elia and Weiyi Liu and Steven Finkbeiner},
journal = {The Journal of clinical investigation},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13668611},
note = {CC BY},
}
RIS
TY - JOUR
TI - Modeling human neurodegeneration with iPSCs: opportunities, limitations, and the challenge of aging
AU - Shijie Wang
AU - Lisa Elia
AU - Weiyi Liu
AU - Steven Finkbeiner
PY - 2026
DA - 2026/10/19
JO - The Journal of clinical investigation
UR - https://europepmc.org/article/PMC/PMC13668611
SN - 0021-9738
SN - 1558-8238
ER -